B7MEZ2 Putative glutamate--cysteine ligase 2 MolNFT, Molecular NFT on GenesisL1

Putative glutamate--cysteine ligase 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeifvidowxuduugfawdu57ta4ic534cauco5nune7c6x4yyzeflucxy/metadata.json

IPFS of structure file:

bafybeiamgvi6mpubjmrw2yxf53sdo25r454syaypo7qvl3exmxs2phf5qu/AF-B7MEZ2-F1-model_v2.pdb

First NFT owner address (eip-55):

0x30761E4269B140D1A43C0cF729113D5d800157D0

First NFT owner address (bech32):

genesis1xpmpusnfk9qdrfpupnmjjyfatkqqz47sphmh09

Current NFT ID #144305 owner (web3):

0x30761E4269B140D1A43C0cF729113D5d800157D0

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
144305
Accession (UniProt):
B7MEZ2
Name::
Putative glutamate--cysteine ligase 2
Experimental Method:
Predicted structure
Sequence source:
ESCHERICHIA COLI O45:K1 (STRAIN S88 / EXPEC)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B7MEZ2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B7MEZ2|GCS2_ECO45 Putative glutamate--cysteine ligase 2 OS=Escherichia coli O45:K1 (strain S88 / ExPEC) OX=585035 GN=ybdK PE=3 SV=1 MPLPDFHVSEPFTLGIELEMQVVNPPGYDLSQDSSMLIDAVKNQITAGEVKHDITESMLELATDVCRDINQAAGQFSAMQKVVLQAAADHHLEICGGGTHPFQKWQRQEVCDNERYQRTLENFGYLIQQATVFGQHVHVGCASGDDAIYLLHGLSRFVPHFIALSAASPYMQGTDTRFASSRPNIFSAFPDNGPMPWVSNWQQFEALFRCLSYTTMIDSIKDLHWDIRPSPHFGTVEVRVMDTPLTLSHAVNMAGLIQATAHWLLTERPFKHQEKDYLLYKFNRFQACRYGLEGVITDPHTGDRRSLTEATLRLLEKIAPSAHKIGASSAIEALHRQVVSGLNEAQLMRDFVADGGSLIGLVKKHCEIWAGE

B7MEZ2 AF NFT

MOLNFT AF v1

NFT data

MOLNFT B7MEZ2 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience